A number of recent trials have explored potential strategies for using immunotherapy in chronic lymphocytic leukemia (CLL). The authors explained that while molecularly targeted therapies like Bruton ...
Positive Phase 1 data confirm MP0317’s tumor-localized CD40 activation with a favorable safety profile in patients with advanced cancer ...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that a study co ...
Malignant tumor treatment remains a major challenge due to the limited precision and significant side effects. Copper-based ...
Researchers at Baylor College of Medicine and collaborating institutions have developed a method that reveals the cellular makeup of tissues that support metastatic cancer growth, which is the primary ...
Further acknowledgement and study of the tumor microenvironment in diffuse large B-cell lymphoma (DLBCL) could eventually result in much more personalized—and effective—treatments. DLBCL being ...
The Korea Research Institute of Standards and Science has unveiled a new principle for controlling the microenvironment of biological tissues to promote wound healing and regeneration. This discovery ...
This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...
Aberrantly expressed lncRNAs within the TME are emerging as critical players in tumor growth, progression, metastasis, and drug resistance. These lncRNAs influence a wide range of cellular processes, ...
Chemokines, acting as "traffic controllers" in the tumor microenvironment, regulate immune cell infiltration and local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results